Forte Biosciences (FBRX) Short Interest Ratio & Short Volume → Buy Friday, Sell Monday, No Exceptions (From DTI) (Ad) Free FBRX Stock Alerts $0.70 +0.00 (+0.19%) (As of 03:59 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Forte Biosciences Short Interest DataCurrent Short Volume42,200 sharesPrevious Short Volume66,600 sharesChange Vs. Previous Month-36.64%Dollar Volume Sold Short$26,164.00Short Interest Ratio / Days to Cover1.2Last Record DateMarch 15, 2024Outstanding Shares36,400,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume52,347 sharesAverage Trading Volume34,737 sharesToday's Volume Vs. Average151% Short Selling Forte Biosciences ? Sign up to receive the latest short interest report for Forte Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFBRX Short Interest Over TimeFBRX Days to Cover Over TimeFBRX Percentage of Float Shorted Over Time Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here Forte Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202442,200 shares $26,164.00 -36.6%N/A1.2 $0.62 2/29/202466,600 shares $45,474.48 -17.2%N/A1.6 $0.68 2/15/202480,400 shares $55,910.16 +62.4%N/A2.1 $0.70 1/31/202449,500 shares $30,199.95 -28.7%N/A1.1 $0.61 1/15/202469,400 shares $51,356.00 -55.4%N/A1.8 $0.74 12/31/2023155,500 shares $127,774.35 +57.1%N/A3.9 $0.82 Get the Latest News and Ratings for FBRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Forte Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/15/202399,000 shares $74,250.00 +40.4%N/A2.5 $0.75 11/30/202370,500 shares $33,417.00 +21.6%N/A1.7 $0.47 11/15/202358,000 shares $22,045.80 +3.2%N/A1.5 $0.38 10/31/202356,200 shares $27,594.20 -2.9%N/A1.8 $0.49 10/15/202357,900 shares $33,020.37 -10.9%N/A0.7 $0.57 9/30/202365,000 shares $43,030.00 -0.8%N/A0.8 $0.66 9/15/202365,500 shares $53,683.80 -1.8%N/A0.8 $0.82 8/31/202366,700 shares $55,367.67 -7.6%N/A0.8 $0.83 8/15/202372,200 shares $59,204.00 +38.3%N/A0.9 $0.82 7/31/202352,200 shares $52,722.00 -7.6%N/A0.7 $1.01 7/15/202356,500 shares $56,500.00 -0.9%N/A1.8 $1.00 6/30/202357,000 shares $59,280.00 +4.8%N/A0.9 $1.04 6/15/202354,400 shares $56,032.00 +0.4%N/A0.9 $1.03 5/31/202354,200 shares $55,284.00 -4.1%N/A0.8 $1.02 5/15/202356,500 shares $61,076.50 -15.7%N/A0.8 $1.08 4/30/202367,000 shares $71,690.00 -42.4%N/A1 $1.07 4/15/2023116,400 shares $125,712.00 +203.9%N/A1.7 $1.08 3/31/202338,300 shares $38,683.00 -27.3%N/A0.6 $1.01 3/15/202352,700 shares $51,999.09 -23.0%N/A1.3 $0.99 2/28/202368,400 shares $69,768.00 +0.4%N/A1.7 $1.02 2/15/202368,100 shares $68,100.00 -2.4%N/A1.7 $1.00 1/31/202369,800 shares $69,800.00 +0.7%N/A1.7 $1.00 1/15/202369,300 shares $70,686.00 -39.5%N/A1.7 $1.02 12/30/2022114,500 shares $114,500.00 +36.8%N/A2.8 $1.00 12/15/202283,700 shares $85,374.00 -16.3%N/A2.1 $1.02 11/30/2022100,000 shares $99,480.00 -19.4%N/A1.9 $0.99 11/15/2022124,100 shares $124,100.00 +17.1%N/A1.9 $1.00 10/31/2022106,000 shares $114,480.00 +1.7%N/A1.2 $1.08 10/15/2022104,200 shares $107,326.00 -10.8%N/A0.7 $1.03 9/30/2022116,800 shares $124,976.00 +8.4%N/A0.6 $1.07 9/15/2022107,800 shares $137,984.00 -2.3%N/A0.4 $1.28 8/31/2022110,300 shares $143,390.00 -30.6%N/A0.4 $1.30 8/15/2022159,000 shares $206,700.00 -3.0%N/A0.6 $1.30 7/31/2022163,900 shares $203,236.00 +7.2%1.4%0.6 $1.24This consistently signaled gains of 453%... 610%... and even 1036%... (Ad)It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. FBRX Short Interest - Frequently Asked Questions What is Forte Biosciences' current short interest? Short interest is the volume of Forte Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 42,200 shares of FBRX short. Learn More on Forte Biosciences' current short interest. What is a good short interest ratio for Forte Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FBRX shares currently have a short interest ratio of 1.0. Learn More on Forte Biosciences's short interest ratio. Which institutional investors are shorting Forte Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Forte Biosciences: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Forte Biosciences' short interest increasing or decreasing? Forte Biosciences saw a drop in short interest in March. As of March 15th, there was short interest totaling 42,200 shares, a drop of 36.6% from the previous total of 66,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Forte Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Forte Biosciences: MEI Pharma, Inc. (0.15%), Cumberland Pharmaceuticals Inc. (0.25%), Sensei Biotherapeutics, Inc. (0.90%), Lisata Therapeutics, Inc. (0.15%), CalciMedica, Inc. (0.19%), TherapeuticsMD, Inc. (0.47%), Indaptus Therapeutics, Inc. (1.70%), Lipocine Inc. (2.40%), NeuroSense Therapeutics Ltd. (0.38%), Lumos Pharma, Inc. (6.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Forte Biosciences stock? Short selling FBRX is an investing strategy that aims to generate trading profit from Forte Biosciences as its price is falling. FBRX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Forte Biosciences? A short squeeze for Forte Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FBRX, which in turn drives the price of the stock up even further. How often is Forte Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBRX, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MEI Pharma Short Squeeze Cumberland Pharmaceuticals Short Squeeze Sensei Biotherapeutics Short Squeeze Lisata Therapeutics Short Squeeze CalciMedica Short Squeeze TherapeuticsMD Short Squeeze Indaptus Therapeutics Short Squeeze Lipocine Short Squeeze NeuroSense Therapeutics Short Squeeze Lumos Pharma Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FBRX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry ResearchSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace